Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Gleevec/Glivec

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Gleevec/Glivec was produced by Novartis.

FDA clears Blueprint’s $32k-per-month GI cancer drug

FDA clears Blueprint’s $32k-per-month GI cancer drug

Chemotherapy and radiotherapy is notoriously ineffective in GIST. At the moment the standard approach to treating patients who aren’t eligible for surgery is older kinase inhibitor drugs like Novartis’ Glivec

Novartis aims for 10 blockbuster launches by 2020

Novartis aims for 10 blockbuster launches by 2020 On the downside, revenues from post-patent expiry cancer drug Glivec continued to decline (down 20% to $1.56bn).

Biopharma's Future: Made in China

Biopharma's Future: Made in China Novartis’ leukaemia treatment Glivec.

Novartis gets speedy reviews for new Kymriah filings

Novartis gets speedy reviews for new Kymriah filings as Glivec (imatinib) are succumbing to generic competition.

Novartis Oncology head Bruno Strigini to retire

Novartis Oncology head Bruno Strigini to retire He has navigated the business unit through the Gleevec patent expiration and has led the successful integration of the GSK Oncology Product Portfolio acquired in 2015.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Skills in Healthcare

At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics